Sarcomas Arising in Paget Disease of Bone: A Clinicopathologic Analysis of 70 Cases

• Published in: Archives of pathology & laboratory medicine (1976) Vol. 131; no. 6; pp. 942 - 946
• Main Authors: Deyrup, Andrea T., Montag, Anthony G., Inwards, Carrie Y., Xu, Zhiheng, Swee, Ronald G., Krishnan Unni, K.
• Format: Journal Article
• Language: English
• Published: United States College of American Pathologists 01.06.2007
• Subjects: Adult; Aged; Aged, 80 and over; Bone cancer; Bone Neoplasms - mortality; Bone Neoplasms - pathology; Bone Neoplasms - therapy; Bones; Care and treatment; Chemotherapy; Combined Modality Therapy; Comorbidity; Female; Fractures; Humans; Male; Medical prognosis; Men; Metastasis; Middle Aged; Osteitis deformans; Osteitis Deformans - mortality; Osteitis Deformans - pathology; Osteitis Deformans - therapy; Osteosarcoma - mortality; Osteosarcoma - pathology; Osteosarcoma - therapy; Patients; Prognosis; Retrospective Studies; Risk factors; Sarcoma; Survival Rate; Tumors; United States
• ISSN: 0003-9985; 1543-2165; 1543-2165
• DOI: 10.5858/2007-131-942-SAIPDO

Context.—Sarcomatous transformation is a rare complication of Paget disease of bone. Prognosis in patients with other types of sarcomas arising in bone has improved in the last several decades because of therapeutic advances. However, because of the rarity of Paget sarcoma, outcome studies in these patients are limited. Objective.—To determine whether prognosis for Paget sarcoma has improved. Design.—Seventy cases of sarcomas arising in the setting of Paget disease were collected, and the histologic and clinical findings were reviewed. Clinical follow-up was obtained in 67 cases. Results.—Sarcoma arising in Paget disease tended to arise in older men (46 men, 24 women; age range, 31–88 years; mean age, 66 years) and predominated in the axial skeleton (n = 37), especially in the pelvis. Thirty-three patients had a clinical history of Paget disease ranging in duration from 16 months to 30 years (mean, 15 years). No significant difference in incidence between monostotic (n = 33) and polyostotic (n = 36) disease was noted. Most tumors were osteosarcomas (88%). All tumors were high grade. Follow-up information was obtained in 67 of 70 cases (range of follow-up, 1–252 months). Survival ranged from 1 month to 20 years, with a 5-year survival rate of 10%. Conclusions.—Prognosis remains poor in patients with Paget sarcoma. There is no significant correlation between the number of bones involved with Paget disease or the duration of disease and development of Paget sarcoma. Poor prognosis in Paget sarcoma is unrelated to site or stage at presentation.